J. Goldman & Co’s Nu Skin NUS Stock Holding History

J. Goldman & Co’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-16,111	Closed	-$111K	–	579
2024 Q4	$111K	Buy	+16,111	New	+$111K	﹤0.01%	415

Other funds holding NUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

J. Goldman & Co's NUS Position: Q1 2025 in Review

J. Goldman & Co sold out of Nu Skin (NUS) in Q1 2025, closing a stake of 16,111 shares — an estimated $111K sold.

J. Goldman & Co first reported a position in NUS in Q4 2024 and held it in 1 quarter. The position peaked at $111K in Q4 2024. 195 funds tracked by Wall St. Rank hold NUS as of Q1 2025.

J. Goldman & Co reported no remaining Nu Skin position as of Q1 2025 after selling out during the quarter.
J. Goldman & Co sold 16,111 Nu Skin shares in Q1 2025, an estimated $111K.
J. Goldman & Co first reported a position in Nu Skin in Q4 2024 and held it in 1 quarter.
J. Goldman & Co's Nu Skin position peaked at $111K in Q4 2024.
195 funds tracked by Wall St. Rank held Nu Skin as of Q1 2025.

Based on J. Goldman & Co's 13F filing for Q1 2025, filed 15 May 2025.